Search

Through converging lines of research in stem cell biology, tissue regeneration, and immunity, Sloan Kettering Institute scientists are learning what makes metastatic cancer cells tick.

MSK nurses receive prestigious Magnet® designation for the second time during an especially challenging year.

COVID-19 is continuing to make headlines around the world this year. Yet cancer will kill a larger number of people globally – 10 million every year. Patients with cancer are more vulnerable to contracting COVID-19, and have more than double the death rate from COVID-19 compared to patients without cancer.

Neuropathologist and scientist Jason T. Huse has been selected by the Sontag Foundation as one of three Distinguished Scientist Award recipients for 2012.

Neuro-oncologist and renowned physician-scientist Ingo Mellinghoff will lead MSK’s distinguished Department of Neurology after previously serving as Acting Co-Chair.

Memorial Sloan Kettering Cancer Center chemist Samuel J. Danishefsky will be honored with three major awards this spring. Dr. Danishefsky is the incumbent of a Eugene W. Kettering Chair and a member of the Molecular Pharmacology and Chemistry Program in the Sloan Kettering Institute.

President Biden announced on September 15 his appointment of MSK medical oncologist and Head of the Division of Solid Tumor Oncology, Luis Alberto Diaz, Jr., MD, as one of seven distinguished members of the National Cancer Advisory Board.

MSK Kids is continuously investigating new ways to improve outcomes and the quality of life for pediatric patients with high-risk neuroblastoma. In this article we detail highlights of the latest clinical and molecular research advances for pediatric neuroblastoma.